Is brexafemme (Bexarotene?) still available in the US?
Brexafemme is a brand name for ibrexafungerp, an antifungal medicine approved for certain fungal infections. Based on the information available here, I can’t confirm current stock or whether the product is still on the market, because availability can change by country, pharmacy, and time.
If you tell me your country (and whether you mean the US brand “Brexafemme”), I can narrow the answer to what’s typically checked for availability there (manufacturer supply, pharmacy status, and official listings).
What to check if your pharmacy says it’s unavailable
Even when a drug is approved, it may be temporarily hard to source. For current availability, people usually check:
- Whether your pharmacy can order it from their distributor or needs a direct-from-manufacturer order
- Expected delivery date and whether they can substitute a different form of ibrexafungerp (if approved in your region)
- Whether the prescriber can switch to an alternative antifungal covered for your condition (depends on the exact diagnosis)
How long shortages usually last (and how to find the most current status)
Drug supply issues can be short-term or prolonged, and the fastest way to verify is to check:
- Your pharmacy’s real-time ordering status
- The drug’s most recent communications from the manufacturer (if there’s a supply update)
What alternatives are used if Brexafemme can’t be obtained
Alternatives depend on why it was prescribed (the specific fungal infection and severity). Your clinician may consider other antifungals that are commonly used for similar indications, but the right switch depends on your diagnosis and risk factors.
Quick questions to pinpoint your situation
Reply with:
1) Your country
2) Whether you mean Brexafemme (ibrexafungerp)
3) The infection it was prescribed for (if you know it)
Then I can give a more precise, practical answer about whether it’s typically available and what options exist if it’s not.